M Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Lightcast lands £20m in funding led by ARCH Venture Partners to advance single-cell analysis platform
Lightcast is a life science tools startup that develops a benchtop platform for functional single-cell analysis. Its technology enables researchers to directly measure how individual cells behave, supporting applications such as antibody discovery, cell therapy, and immunology research.
NRG Therapeutics lands £50m Series B led by SV Health Investors to advance neurodegenerative disease therapies
NRG Therapeutics develops oral small-molecule drugs targeting mitochondrial dysfunction, aiming to slow or halt neurodegenerative diseases such as ALS and Parkinson’s through disease-modifying treatments.
TRIMTECH raises £24m seed led by Cambridge Innovation Capital and SV Health Investors to advance neurodegenerative treatments
TRIMTECH Therapeutics develops targeted protein degradation medicines that selectively remove harmful protein aggregates, focusing on neurodegenerative and inflammatory diseases with limited existing treatment options.
- 2(12 months)
- m-ventures.com
- Update Information
More venture news
- 29 Apr 2026
Third Space LearningThird Space Learning secures £4.4m in funding from Maven and Blackfinch Ventures to scale its AI tutoring platform
EquityEducation - 30 Apr 2026
Online OceansOnline Oceans lands £4m in funding led by Seraphim Space to build autonomous maritime surveillance fleets
EquityDefence - 27 Apr 2026
PlaqueTecPlaqueTec raises £3.7m investment from existing backers to develop site-of-disease cardiovascular insights
EquityHealth
